Tue, June 6, 2023
Mon, June 5, 2023
Sat, June 3, 2023
Fri, June 2, 2023
Thu, June 1, 2023

Ed Arce Reiterated (AKBA) at Hold and Held Target at $2 on, Jun 2nd, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-hold-and-held-target-at-2-on-jun-2nd-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Ed Arce of HC Wainwright & Co., Reiterated "Akebia Therapeutics, Inc." (AKBA) at Hold and Held Target at $2 on, Jun 2nd, 2023.

Ed has made no other calls on AKBA in the last 4 months.



There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed


  • Christopher Raymond of "Piper Sandler" Upgraded from Hold to Buy and Increased Target to $4 on, Wednesday, May 31st, 2023

Publication Contributing Sources